Skip to content
Back to event

KalshiKalshi· Science and Technology

When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List?

Chance

12%

Buy Yes

20¢

pays $1 if it happens

Buy No

96¢

pays $1 if it doesn’t

Prices from Kalshi, updated 6 minutes ago. Ends Nov 1, 4:59 AM UTC.

Price over the last 2 weeks
Cost of a Yes share

Latest trades

  • 5 hours agoBought no at 94¢$28
  • 5 hours agoBought no at 85¢$29
  • 5 hours agoBought no at 84¢$4
  • 5 hours agoBought no at 86¢$430
  • yesterdayBought no at 85¢$21
How this market is decidedShow

If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Nov 1, 2026, then the market resolves to Yes. The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility. Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion.